MicroPort Scientific Corp (MicroPort) develops, manufactures and markets medical equipment. The company’s product range includes cardiovascular, orthopaedic, cardiac rhythm management, electrophysiology, endovascular, neurovascular devices, and surgical robots. It offers diabetes and endocrinal management devices such as insulin and hypophyseal hormone infusion pumps.

Microport also produces interventional technology solutions, rehabilitation tools, and devices for reproductive health. The company’s products are used for patients suffering from coronary artery disease, joint replacement, abnormal heartbeat, stroke, severe aortic valve stenosis, aortic aneurysm, and arteriosclerosis.

It has operational presence across Europe, Asia-Pacific, and North and Latin America. MicroPort is headquartered in Shanghai, China.